The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease.

Dig Liver Dis

IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. Electronic address:

Published: February 2023

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2022.10.007DOI Listing

Publication Analysis

Top Keywords

role ustekinumab
4
ustekinumab vedolizumab
4
vedolizumab management
4
management extra
4
extra intestinal
4
intestinal manifestations
4
manifestations inflammatory
4
inflammatory bowel
4
bowel disease
4
role
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!